GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » FCF Margin %

Nuformix (LSE:NFX) FCF Margin % : 0.00% (As of Sep. 2022)


View and export this data going back to 2015. Start your Free Trial

What is Nuformix FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Nuformix's Free Cash Flow for the six months ended in Sep. 2022 was £-0.34 Mil. Nuformix's Revenue for the six months ended in Sep. 2022 was £0.00 Mil. Therefore, Nuformix's FCF Margin % for the quarter that ended in Sep. 2022 was 0.00%.

As of today, Nuformix's current FCF Yield % is 0.00%.

The historical rank and industry rank for Nuformix's FCF Margin % or its related term are showing as below:

LSE:NFX' s FCF Margin % Range Over the Past 10 Years
Min: -866   Med: 0   Max: 0
Current: -866


LSE:NFX's FCF Margin % is ranked worse than
74.16% of 1041 companies
in the Biotechnology industry
Industry Median: -141.21 vs LSE:NFX: -866.00


Nuformix FCF Margin % Historical Data

The historical data trend for Nuformix's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix FCF Margin % Chart

Nuformix Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
FCF Margin %
Get a 7-Day Free Trial -10,880.00 -53.44 -142.24 -431.63 -2,692.00

Nuformix Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -1,196.00 - - -

Competitive Comparison of Nuformix's FCF Margin %

For the Biotechnology subindustry, Nuformix's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nuformix's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuformix's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Nuformix's FCF Margin % falls into.



Nuformix FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Nuformix's FCF Margin for the fiscal year that ended in Mar. 2022 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2022 )/Revenue (A: Mar. 2022 )
=-1.346/0.05
=-2,692.00 %

Nuformix's FCF Margin for the quarter that ended in Sep. 2022 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2022 )/Revenue (Q: Sep. 2022 )
=-0.338/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuformix FCF Margin % Related Terms

Thank you for viewing the detailed overview of Nuformix's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuformix (LSE:NFX) Business Description

Traded in Other Exchanges
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.

Nuformix (LSE:NFX) Headlines

From GuruFocus

Newfield Exploration Company (NFX) EVP and COO Gary D Packer sells 23,000 Shares

By GuruFocus Research GuruFocus Editor 03-11-2010

Newfield Exploration Company (NFX) EVP and COO Gary D Packer sells 10,000 Shares

By GuruFocus Research GuruFocus Editor 12-29-2009

Newfield Exploration Company (NFX) EVP and COO Gary D Packer sells 15,000 Shares

By GuruFocus Research GuruFocus Editor 12-13-2010